Go to the list of all blogs
Jimmy Landsman's Avatar
published in Blogs
Jul 31, 2026
SOXS Rallies +35% Over 30 Days as Semiconductor Stocks Correct

SOXS Rallies +35% Over 30 Days as Semiconductor Stocks Correct

Key Takeaways

  • SOXS surged approximately 35% over the past 30 days as semiconductor stocks entered a sharp and broad-based correction.
  • Over the full quarter, SOXS remains down roughly 60%, reflecting the powerful semiconductor rally that preceded the July selloff and the compounding effects of daily leveraged inverse exposure.
  • The Philadelphia Semiconductor Index fell more than 20% from its late-June record peak, crossing into bear-market territory and driving inverse-leveraged instruments sharply higher.
  • Primary catalysts for the chip selloff include intensifying concerns about AI infrastructure spending sustainability, rising Chinese semiconductor competition, a high-profile earnings miss from SK Hynix, and broad profit-taking across overextended positions.
  • As a -3x daily leveraged inverse ETF, SOXS is designed for short-term tactical trading and is not suitable as a long-term buy-and-hold instrument due to volatility decay and compounding effects.

Understanding SOXS and Its Semiconductor Exposure

The Direxion Daily Semiconductor Bear 3X Shares seeks daily investment results, before fees and expenses, corresponding to 300% of the inverse of the daily performance of the ICE Semiconductor Index. The underlying index tracks the 30 largest U.S.-listed semiconductor companies on a modified float-adjusted market capitalization-weighted basis. SOXS launched in March 2010 and carries a net expense ratio of about 1.00%, with recent AUM fluctuating between $1.3 billion and $2.0 billion.

SOXS achieves its inverse exposure mainly through swap agreements, futures, and other derivatives rather than holding individual stocks. Its collateral consists primarily of cash, Treasury securities, and short-term government instruments. Key index constituents include NVDA (NVIDIA), AVGO (Broadcom), AMD (Advanced Micro Devices), QCOM (Qualcomm), TXN (Texas Instruments), AMAT (Applied Materials), LRCX (Lam Research), MU (Micron Technology), MRVL (Marvell Technology), and INTC (Intel). Declines in these names translate directly into magnified daily gains for SOXS.

Price Performance: +35% in 30 Days Against a 60% Quarterly Drop

Over the past 30 days SOXS advanced roughly 35%, moving from the low-$30s to low-$40s in late June and early July into the low-to-mid $50s. The advance featured the sharp intraday volatility typical of leveraged inverse products, yet the net direction aligned with the semiconductor index’s steepest pullback since 2022.

Looking at the full quarter tells a different story. SOXS fell about 60% from near $130 in early May to current levels around $52. This outcome stems from the strong semiconductor rally through the second quarter of 2026, when both the ICE Semiconductor Index and the Philadelphia Semiconductor Index hit record highs. Daily compounding in a -3x structure amplified the drawdown during the upward move, and the July rebound has only partially offset it.

What Fueled the Recent 30-Day Advance

The 35% gain in SOXS tracked a broad selloff in semiconductor equities. The Philadelphia Semiconductor Index dropped more than 20% from its late-June peak, entering bear-market territory. Several factors converged to drive the decline.

Investor concerns grew over the sustainability of AI infrastructure spending. Even with solid hyperscaler earnings, questions arose about whether hundreds of billions in data-center outlays would deliver sufficient returns. Reports of circular financing arrangements among AI startups and manufacturers added to the skepticism.

Chinese competition also weighed on sentiment. A state-backed firm reportedly began mass-producing immersion deep ultraviolet lithography equipment, while CXMT completed a major IPO to expand memory production. Fears of a supply glut hit memory names such as MU especially hard, with multiple double-digit down days.

SK Hynix posted a second-quarter earnings miss despite record revenue and profit, triggering a selloff that spread across global semiconductor stocks. Major U.S. names including NVDA, AMD, INTC, and AVGO all declined during the period. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Finally, the Federal Reserve’s higher-for-longer rate signal prompted rotation out of high-beta growth stocks into defensives, adding pressure on chip equities and supporting inverse products like SOXS.

Quarterly Drivers and the Impact of Daily Compounding

From early May through late June the ICE Semiconductor Index climbed to successive highs amid peak AI enthusiasm, briefly making Nvidia the world’s most valuable company. SOXS, delivering -3x the daily index return, fell from roughly $130 to below $33 at its trough. The quarterly decline was magnified by the mathematics of daily reset in a strongly trending market, a classic example of how leveraged inverse products can diverge from a simple -3x multiple over multi-day periods.

Key Factors to Watch Going Forward

Future moves in SOXS will hinge on whether the semiconductor correction extends or settles into a valuation reset within an ongoing AI cycle. Earnings guidance from major technology companies and hyperscalers will be critical, as will any updates on Chinese production capacity and U.S. export controls. Monetary policy signals from the Federal Reserve will also influence risk appetite. Given the daily-reset mechanics of SOXS, position sizing and holding periods require careful attention to volatility and fund flows.

AI-Powered ETF Screening in Practice

In my research process, I frequently turn to Tickeron’s AI Screener. It lets me scan thousands of securities with customizable filters for technical patterns, fundamentals, volatility, and industry exposure, delivering AI-driven signals that help surface tactical setups faster than manual methods. For instruments like SOXS, where timing matters, the platform has become a practical part of monitoring shifting conditions.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: SOXS

Contributor

My name is Jimmy, and I’m a financial analyst. I’m passionate about identifying the most promising ETFs for trading. Every day, I review hundreds of ETFs in search of trading and investment signals based on a variety of factors. I actively use technical analysis to identify short-term opportunities, including channels, indicators, support and resistance levels, and more. I also spend a great deal of time researching ETFs from a long-term investment perspective. My goal is to build a balanced ETF portfolio that combines investment-oriented and speculative ETFs and performs effectively during both market rallies and corrections.


SOXS's RSI Indicator peaks and leaves overbought zone

The 10-day RSI Indicator for SOXS moved out of overbought territory on July 30, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 18 instances where the indicator moved out of the overbought zone. In of the 18 cases the stock moved lower in the days that followed. This puts the odds of a move down at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on August 06, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on SOXS as a result. In of 93 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for SOXS turned negative on August 05, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at .

SOXS moved below its 50-day moving average on August 04, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for SOXS crossed bearishly below the 50-day moving average on August 12, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SOXS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

SOXS broke above its upper Bollinger Band on July 28, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +3 3-day Advance, the price is estimated to grow further. Considering data from situations where SOXS advanced for three days, in of 252 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 101 cases where SOXS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Industry description

The investment seeks daily investment results, before fees and expenses, of 300% of the inverse (or opposite) of the daily performance of the ICE Semiconductor Index. The fund invests at least 80% of the fund’s net assets in financial instruments, that, in combination, provide 3X daily inverse (opposite) or short exposure to the index or to ETFs that track the index, consistent with the fund’s investment objective. The index is a rules-based, modified float-adjusted market capitalization-weighted index that tracks the performance of the thirty largest U.S. listed semiconductor companies. The fund is non-diversified.
View a ticker or compare two or three
SOXS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Category Trading

Profile
Details
Category
Trading--Inverse Equity
Address
Direxion Shares ETF Trust33 Whitehall Street,10th FloorNew York
Phone
866-476-7523
Web
http://www.direxioninvestments.com/
Interact to see
Advertisement
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.
Gogo shares continue to trade near 52-week lows around $4, weighed down by competitive threats from Starlink and slower-than-anticipated AVANCE system upgrades. William Blair downgraded the stock to Market Perform in December 2025, citing leverage concerns and intensifying rivalry in in-flight connectivity.
Quantum Computing Inc. completed a $110 million acquisition of Luminar Semiconductor on February 2, significantly strengthening its photonics and manufacturing capabilities. Shares have traded with elevated volatility, peaking near $12.70 in mid-January before retreating to the $9 range amid heavy volume.
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Golar LNG (GLNG) has remained resilient in recent trading, hovering near the top of its 52-week range as investor interest in floating LNG infrastructure continues to build. The stock is underpinned by a deep FLNG order backlog, steady production from operating assets, and improving financial flexibility.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Apollo Global Management (APO), a leading alternative asset manager, reports Q4 and full-year 2025 results on February 9, 2026, before the market opens. The firm has delivered a year of strong growth, with AUM expanding on record inflows exceeding $200 billion and origination surpassing $300 billion.